Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
For most people in the UK, the NHS is the natural and trusted starting point for any medical concern, and B12 injections are no different
Uedono, Y., Takeyama, N., Yamagami, K
It's the only independent proof that what's in the vial matches what's on the label
Some studies are looking at glutathione's health effects when it's taken by injection or inhaled directly into the lungs
It is chemically a small-molecule, non-peptide compound rather than a true peptide, even though it is routinely grouped alongside peptides such as ipamorelin or CJC-1295 in bodybuilding content because it acts on the same GH/ghrelin pathway